loading...| Preferred Name |
Tapentadol |
|
| Synonyms |
|
|
| Definitions |
An orally available, synthetic benzenoid that acts as an agonist for the mu-opioid receptor (MOR) and inhibits the reuptake of noradrenaline, with potential anti-nociceptive activity. Upon oral administration, tapentadol binds to the MOR which enhances MOR-mediated signaling, interferes with the sensation of pain and results in an analgesic effect. Tapentadol also inhibits the reuptake of noradrenaline, which increases the levels of noradrenaline (NA), activates the inhibitory alpha-2 receptors and results in an analgesic effect. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C72139 |
|
| CAS_Registry |
175591-23-8 |
|
| Chemical_Formula |
C14H23NO |
|
| code |
C72139 |
|
| Contributing_Source |
FDA |
|
| definition |
An orally available, synthetic benzenoid that acts as an agonist for the mu-opioid receptor (MOR) and inhibits the reuptake of noradrenaline, with potential anti-nociceptive activity. Upon oral administration, tapentadol binds to the MOR which enhances MOR-mediated signaling, interferes with the sensation of pain and results in an analgesic effect. Tapentadol also inhibits the reuptake of noradrenaline, which increases the levels of noradrenaline (NA), activates the inhibitory alpha-2 receptors and results in an analgesic effect. |
|
| FDA_UNII_Code |
H8A007M585 |
|
| Has_Salt_Form | ||
| in_subset | ||
| label |
Tapentadol |
|
| Legacy Concept Name |
Tapentadol |
|
| Preferred_Name |
Tapentadol |
|
| prefixIRI |
NCIT:C72139 |
|
| prefLabel |
Tapentadol |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C2001271 |
|
| subClassOf |